01Mechanism of action BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid pentadecapeptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), derived from a body-protection sequence originally identified in human gastric juice
Notably, the direct oxidation of medium-chain fatty acids (MCFAs) is still a controversial issue
If you don't record it straight away - which I didn't in this case - then it can get forgotten because you have all these other things
Su KZ, Li YR, Zhang D, Yuan JH, Zhang CS, Liu Y, Song LM, Lin Q, Li MW, Dong J (2019) Relation of circulating resistin to insulin resistance in type 2 diabetes and obesity: a systematic review and Meta-analysis
Insights on the Use of -Lipoic Acid for Therapeutic Purposes
SIBO occurs when there is an abnormal increase in bacterial populations in the small intestine, leading to various digestive symptoms